NTRA Natera Inc
Company Analysis
Latest News
Farallon Capital Opens Major New $641M Position in Natera (NTRA)
In a recent disclosure, Farallon Capital Management reported establishing a significant new stake in Natera, Inc. (NTRA), a leader in cell-free DNA (cfDNA)...
🟢 Natera is trading 4.78% up in pre-market with no clear company-specific catalyst identified
Natera is trading 4.78% up at $343.40, with no clear August 25, 2026 company-specific catalyst identified. - Latest major company news was August 6, 2026...
🟢 Natera is trading 6% up in pre-market after raised full-year guidance
Natera is trading 5.64% up at $343.15, with the move appearing consistent with continued investor momentum following its August 6 earnings report and raised...
🟢 Natera rises 4.2% — Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results
With Biotech (XBI) up 3.7%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, proxied by the XBI ETF, is trading...
BlackRock Bets $2.96 Billion on Natera, Following Strong Earnings Beat
BlackRock Inc. acquired more than 10.9 million shares of Natera during the second quarter. The stake is valued at approximately $2.96 billion. This investment...
🟢 Natera is trading 4.5% up in pre-market — no fresh company-specific catalyst identified
Natera is trading 4.5% up in pre-market at $325.78 after no fresh company-specific catalyst was identified for August 19, 2026. - Its latest major company...
🔴 Natera is trading 5% down in pre-market as Nasdaq Composite fell 1.18%
Natera is trading 4.94% down now at $298.68 after broader risk-off sentiment pushed futures lower. - The Nasdaq Composite is down 1.18%, while the S&P 500 is...
T. Rowe Price Builds Natera Stake, Following Strong Q2 Results
T. Rowe Price Associates, Inc. disclosed a significant ownership stake in Natera Inc. on August 14, 2026. The firm filed a Schedule 13G indicating the shares...
🔴 Natera is trading 15.91% down today in after-hours trading with no reliable company-specific explanation identified
Natera is trading 15.91% down at $265.69 after-hours on August 12, 2026, with no reliable company-specific explanation identified for the decline. - Natera...
🟢 Natera is trading 8% up in pre-market after earnings beat and raised 2026 guidance
Natera is trading 7.95% up at $337.59 after continued investor response to August 6 earnings showing $752.8 million in revenue, record test volumes, and raised...
🔴 Natera is trading 13.85% down in after-hours trading with no verified company-specific announcement
Natera is trading 13.85% down at $274.25 in after-hours trading, with no verified company-specific announcement emerging on August 10, 2026. - Its latest...
Natera Smashes Q2 Estimates and Lifts Guidance, but Can a Still-Unprofitable Testing Company Justify a $39 Billion Valuation?
Shares of genetic testing company Natera surged 15.3% to $306.01, blasting past the stock's prior 52-week high, after the company delivered a second quarter...
Natera Smashes Q2 Estimates and Lifts Guidance, but Can a Still-Unprofitable Testing Company Justify a $39 Billion Valuation?
Shares of genetic testing company Natera surged 15.3% to $306.01, blasting past the stock's prior 52-week high, after the company delivered a second quarter...
🟢 Natera is trading 21% up today after Q2 revenue beat, raised 2026 guidance
Natera is trading 21% up at $321.21 after reporting $752.8 million in second-quarter revenue, well above expectations, and narrowing its loss to $0.47 per...
🟢 Natera is trading 19% up today after Q2 revenue beat and guidance raise
Natera is trading 19.18% up now at $317.36 after its August 6, 2026 earnings release showed strong second-quarter results and management raised full-year...
🟢 Natera is trading 12.30% up in pre-market after Q2 earnings beat and raised 2026 guidance
Natera is trading at $298.01 (+12.30%) after a Q2 earnings beat that included $752.8 million in revenue, up 37.7% year over year. - Management raised 2026...
🟢 Natera is trading 15.3% up in after-hours trading after Q2 revenue beat and raised 2026 guidance
Natera is trading +15.31% at $306.01 in after-hours trading after reporting Q2 revenue above estimates and raising 2026 revenue guidance. • Q2 revenue reached...
Natera's second quarter 2026 revenue of $753M beat estimates while full-year guidance was raised
Natera reported second quarter 2026 revenue of $752.8 million, up 37.7% year-over-year, and a narrower-than-expected net loss of $67.0 million. The company...
Natera Inc Q2 2026 Earnings Preview: What Analysts Expect on August 06, 2026
Analysts expect Natera to report Q2 2026 revenue of $661.26 million and an EPS loss of $0.49, with the stock currently trading at $270.36, slightly above the...
🟢 Natera is trading 4.8% up today amid broad market gains following cooling inflation data
Natera is trading at $265.80 (+4.78%) as the stock climbs alongside a broader market rally driven by cooling inflation data and positive tech earnings. • The...